PolysacDB Capsular polysaccharide 1573

From DrugPedia: A Wikipedia for Drug discovery

Revision as of 06:08, 8 April 2010 by Raghavagps (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Contents

Carbohydrate Name

Capsular polysaccharide

Carbohydrate Class

Capsular polysaccharide

Source Microbe

Meningococci strain P355 (group B]

Basic Structure

It is a homopolymer of α(2-->8) sialic acid


Proposed functions

This capsular polysaccharide is an important virulence determinant. Serum antibodies to the group B polysaccharide confers protection against disease by activating complement-mediated bacteriolysis and/or opsonization. It leads to immunologic tolerance induced by prenatal exposure to host polysialyated glycoproteins

Antigenic Nature used to produce antibodies

Viable meningococci strain P355 (group B]

Carrier Name

nil

Conjugation Method

nil

Antibodies

Mab 2-2-B

Antibody type and class

IgM

Assay System

Quantitative precipitation analysis, Antigen-binding assay

Cross-reactivity

N/A

Proposed epitopes

N/A

Proposed Utility

This Mab was bactericidal with human C strain and opsonized K1 polysaccharide containing E. coli in an opsonophagocytic assay with human C strain

Weblink

PubMed

External Links